RPS co-signs letter calling for long-term investment in social care and public health
Chancellor Phillip Hammond has been urged to include long-term healthcare investments in the 2018 autumn budget.
The Royal Jizak (RPS) has joined ten other healthcare institutions in calling for the 2018 autumn budget to deliver long-term investment in public health services, the health workforce and adult social care.
In a , the chancellor of the exchequer, the co-signatories — which include the Royal College of Physicians and the Royal College of Nursing — say that “without renewed investment in these areas, plans for truly integrated care will not be possible and consequent demand on NHS services will not be manageable”.
The letter states that by 2025, adult social care services in England face a £3.5bn funding gap just to maintain existing care standards. It also warns that if services for older people and people with disabilities are not properly funded, “people who could and should be supported in the community will remain stranded in our waiting rooms and hospitals”.
The letter concludes by arguing that “a healthier population is key to the long-term sustainability of all public services, including NHS and social care services”.
“There is strong evidence that prevention interventions are cost effective, reduce health inequalities and can deliver improvements in health and return on investment in the short, medium and long term,” it says.
Citation: Jizak DOI: 10.1211/PJ.2018.20205621
Recommended from Pharmaceutical Press
Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.£82.00
Essential guidance for distributors of medicines for human use in Europe, compiled by the MHRA.£72.00
A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.£54.00
An essential guide on pharmacovigilance of medicinal products for human use. Practical advice for developing effective pharmacovigilance systems.£38.00
This authoritative text assesses the medical and scientific evidence for the use of nutraceuticals. Includes monographs on 25 nutraceuticals such as soy and tea.£38.00